Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
As of close of business last night, Spyre Therapeutics Inc’s stock clocked out at $27.65, down -2.74% from its previous closing price of $28.43. In other words, the price has decreased by -$2.74 from its previous closing price. On the day, 0.59 million shares were traded. SYRE stock price reached its highest trading level at $28.67 during the session, while it also had its lowest trading level at $27.33.
Ratios:
To gain a deeper understanding of SYRE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.32 and its Current Ratio is at 7.32. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on September 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $45.
On May 02, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $50.Robert W. Baird initiated its Outperform rating on May 02, 2024, with a $50 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 06 ’24 when Albers Jeffrey W. sold 6,700 shares for $36.76 per share. The transaction valued at 246,313 led to the insider holds 27,360 shares of the business.
Albers Jeffrey W. sold 300 shares of SYRE for $10,929 on Oct 25 ’24. The Director now owns 34,060 shares after completing the transaction at $36.43 per share. On Oct 25 ’24, another insider, SESSIONS, LLC, who serves as the Director of the company, bought 7,000 shares for $33.70 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SYRE now has a Market Capitalization of 1623226368 and an Enterprise Value of 1163666176. As of this moment, Spyre’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.00.
Stock Price History:
Over the past 52 weeks, SYRE has reached a high of $47.97, while it has fallen to a 52-week low of $14.22. The 50-Day Moving Average of the stock is -11.00%, while the 200-Day Moving Average is calculated to be -12.01%.
Shares Statistics:
It appears that SYRE traded 571.28K shares on average per day over the past three months and 894150 shares per day over the past ten days. A total of 51.40M shares are outstanding, with a floating share count of 48.69M. Insiders hold about 17.07% of the company’s shares, while institutions hold 81.97% stake in the company. Shares short for SYRE as of 1731628800 were 8040536 with a Short Ratio of 14.07, compared to 1728950400 on 8413483. Therefore, it implies a Short% of Shares Outstanding of 8040536 and a Short% of Float of 18.450001.
